# BEXLUTRY

NDC: 69945-177
Generic name: LUTETIUM OXODOTREOTIDE LU-177
Labeler / Manufacturer: Curium US LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20260914

FDA application: NDA218525

## Active ingredients

- LUTETIUM OXODOTREOTIDE LU-177: 10 mCi/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69945-177"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69945-177

